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The remainder of the difference was attributed to increased energy requirements for excitation-contraction coupling. Inorganic phosphate concentrations increased more and phosphocreatine concentrations decreased more during low-flow conditions (3 ml/min) when hearts were perfused with hexanoate compared with glucose. Thus hexanoate decreases myocardial efficiency compared with glucose in large part by increasing non-work-related oxygen demands. This inefficiency impacts adversely on contractile strength and high-energy phosphate concentrations at low coronary flows. free fatty acids; glucose; ischemia; myocardial efficiency; pressure-volume area MYOCARDIAL METABOLISM provides the chemical fuel (i.e., ATP) needed to maintain contractile activity and to preserve cellular integrity during conditions of normal and decreased coronary flow. Although the heart is capable of utilizing a variety of substrates, the two most preferred are free fatty acids (FFA) and glucose. Whereas heart muscle will use predominantly FFA in preference to glucose under most conditions (15, 25, 29) , results of several studies suggest that cardiac efficiency (the ratio between ventricular work and oxygen consumption) is greater with glucose utilization (3, 14, 21, 25, 30, 34, 35).
Consequently, the choice of substrate may influence contractile performance during normal coronary flow and particularly during low coronary flow (14, 18, 16, 34).
There are several possible reasons why ventricular efficiency could be greater with glucose than with fatty acids (16). For example, glucose, but not fatty acids, supports anaerobic ATP generation via glycolysis. Also, fatty acids are thought to uncouple oxidative phosphorylation (1, 9, 19) and induce ATP wastage by mitochondria (26). The relative importance of such factors is not entirely clear.
The goal of the present study was to determine, in detail, how metabolic substrates influence the interrelationships between contractile strength, ventricular work, and myocardial oxygen consumption at high and low coronary flows. To further evaluate how substrates impact on myocardial energy demand, the influence of substrate on basal oxygen consumption was measured. Additionally, the impact of substrate-mediated alterations in efficiency on the ability of the heart to maintain intracellular high-energy phosphate stores during periods of low coronary flow were determined using phosphorus nuclear magnetic resonance (NMR) spectroscopy. Finally, the potential role of glycolysis in contributing to differences observed between substrates was assessed through measurement of lactate production at various flows. All studies were performed on isolated rat hearts that were supplied either glucose or hexanoate (a medium-chain FFA) as the exogenous metabolic substrate. The results indicate that FFA decrease myocardial efficiency compared with glucose by increasing nonwork-related oxygen demands. The data further suggest that uncoupling of oxidative phosphorylation may play a role in mediating this increase in myocardial oxygen consumption (MVO~). An important consequence of the FFA-mediated inefficiency is that contractile strength and high-energy phosphates fall to a greater extent during low coronary flows when the heart is forced to utilize hexanoate instead of glucose.
METHODS

Surgical Preparation
Retired male exbreeder rats (Sprague-Dawley) weighing 500-700 g were heparinized (1,000 U ip) and then deeply anesthetized (pentobarbital sodium, loo-150 mg ip). After rapid excision of the heart, the aorta was Perfusate solutions contained (in mM) 144 sodium, 5 potassium, 1.5 calcium, 6 N-Z-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 0.9 magnesium, and 152 chloride. Lidocaine (5 pg/ml) was also added for control of ventricular ectopy. This mixture was warmed to 37OC, the pH was adjusted to 7.40, and the mixture was then divided in two portions. Glucose (5 mM) was added to one portion and hexanoate (1 mM) was added to the other. When the perfusates were prepared in this manner, concentrations of all components were identical except for the metabolic substrate. Solutions were stored in separate containers, equilibrated with 100% O2 before use, and bubbled continuously throughout the experiment. Perfusate was not recirculated.
The flow rate of perfusate was regulated by an adjustable-speed rotary pump (Masterflex, Cole-Parmer, Barrlington, IL) with a digital flowmeter that was calibrated by timed volume collection before each experiment. The fluid passed through a condenser and bubble trap before reaching the heart. The condenser and storage containers were warmed by a constant temperature circulator (VWR 1130, Miles, IL) which maintained the temperature of the perfusate at -37°C.
Two sets of preliminary studies were carried out to ensure that with a glucose concentration of only 5 mM the heart was principally using the exogenous glucose as opposed to endogenous triglycerides.
First, in several experiments, the glucose concentration was increased to 15 mM and insulin (40 U/l) was added to the perfusate. No differences were detected in the performance or oxygen consumption between these two conditions over a range of loading and perfusion pressures. 
NMR Spectroscopy
For experiments in which "IP-NMR spectra were to be measured, the hearts were positioned within a ZO-mm probe of a Bruker AM 360-WB NMR spectrometer (field strength 8.5 T). Hearts were paced using a KC1 wick electrode that was placed into the right ventricle. Magnetic field homogeneity was optimized during observation of the water proton signal using the decoupler coil. Proton-decoupled, minimally saturated 'lP spectra were obtained with a 2.1-s delay between pulses of 22~s duration (approximate flip angle of 60") using a 2K data pounds were determined by integrating the area under individual peaks by hand digitization (model 2210 digitizing board, Jandel Scientific, Corte Madera, CA) using commercially available software (SigmaScan, Jandel Scientific). The area under each peak was corrected for the degree of saturation and nuclear Overhauser effect (NOE), with scaling factors determined by comparison of spectra determined with the 2.1-s delay to fully relaxed spectra (delay of 10 s) with minimal NOE. At the beginning of each experiment a series of spectra were obtained during graded increments of intraventricular balloon volume with solution containing phenylphosphonic acid (either 100 or 50 mM, pH 7.4). The areas of this peak from these spectra provided a calibration curve for absolute metabolite quantification (37). Thus all values are presented as moles per gram of wet weight. Intracellular pH was indexed by the chemical shift of the inorganic phosphate (Pi) peak relative to the phosphocreatine (PCr) peak (23).
Protocols
Experiments were carried out on five groups of hearts. All hearts were allowed to equilibrate for 30 min before the start of the experiment.
In each protocol, measurements were made with the hearts alternately perfused with solutions containing either glucose or hexanoate; the glucose substrate was tested first in half the hearts and hexanoate was tested first in the other half. In no case did the results depend on the order in which the substrates were tested, and no distinction will be made below. Enough time was allowed to pass after a switch in substrate for performance and oxygen consumption to reach stable states, and this was typically between 10 and 15 min. All measurements were made under steadystate conditions. Substrate dependence of ventricular contractile strength and efficiency at normal perfusion pressure. The purpose of the first protocol was to determine the substrate dependence of ventricular contractile strength and efficiency at a normal perfusion pressure. Contractile strength was assessed by measurement of the end-systolic pressure-volume relation (ESPVR) (28). Ventricular efficiency was assessed by measurement of the relationships between MVoz and two indexes of mechanical work: the rate-pressure product and the pressure-volume area (defined below). Coronary flow was adjusted to provide a perfusion pressure of 80 mmHg at the beginning of the experiment and was fixed at this value throughout the experiment. Coronary flows averaged 18 t 4 ml/min (11.6 t 1.7 mlog-l~min-l). The basic protocol, performed in 10 hearts, consisted of measuring Paz in the coronary venous effluent, end-diastolic pressure, and end-systolic pressure at each of several balloon volumes during glucose or hexanoate perfusion. Ventricular volume was varied over an average range of 0.35 ml (from 0.2 to 0.55) in increments of 0.05-0.10 ml. The order in which volume was changed was varied randomly from one experiment to the next f. Arteria .l PO 2 wa .s measured at the beginning and at the end of a run, and this served to test the stability of the electrode system during the data-acquisition period as well as to provide the upper limit calibration signal for the electrode. Stability of ventricular performance was checked by making measurements at different times but at the same volume settings over the experimental period. Measurements were made at as many left ventricular volume settings as possible (range each substrate.
4-10) over an -20-min time period with
Substrate dependence of ventricular efficiency at reduced coronary flows. In the second protocol (n = 8) the interrelations among coronary flow, Mvo2, developed pressure, and rate-pressure product were determined during glucose and hexanoate perfusion in each heart. End-diastolic pressure, end-systolic pressure, and both arterial and venous Pop were determined at the control coronary flow rate (chosen to be 15 ml/min). Flow was then set at one of four test levels (7,9, 12, or 20 ml/min), and the same measurements taken under steady-state conditions. The perfusate was then changed, and the measurements were repeated. Finally, the measurements were repeated after flow was restored to the control level with the second substrate. This procedure was repeated for each of the test flows. The order in which the test flows were used was randomized in each experiment. th Substrate dependence of basal metabolism. To assess .e degree to which changes in MVo2 detected in the first series resulted from substrate dependence of basal . metabolism, MVo2 was measured before and during hyperkalemic cardiac arrest in six mechanically unloaded hearts. To obtain mechanically unloaded contractions, no balloon was placed in the ventricles and a thin vent was placed into the chamber through the mitral valve so that no external pressure could be generated by the ventricle. The solutions used to arrest the hearts contained 20 mM KC1 and NaCl decreased to 125 mM (so as to maintain osmotic pressure the same as control ) and either glucose or hexanoate; the other constituents were identical to those of the standard solutions. MTjo2 was measured under four conditions: during unloaded, beating conditions with the first substrate; during arrest with the first substrate; during arrest with the second substrate; and during beating conditions with the second substrate.
Impact of substrate on phosphate metabolite concentrations at low coronary flow. In this protocol (n = 7) 31P-NMR spectra were measured at one high flow (20 ml/ min) and one low flow (3 ml/min) with both glucose and hexanoate perfusion. This low flow was chosen because results of five preliminary experiments indicated that changes in pH, [Pi] 7 [PCr], and [ATP] were relatively small with less severe reductions in coronary flow during hexanoate and especially during glucose perfusion. Enddiastolic and end-systolic pressures and data for determination of a "IP-NMR spectrum were measured after a 30-min stabilization period at a flow of 20 ml/min. Ventricular pressure was allowed to stabilize for -2.5 min at the low flow rate and a 144-pulse spectrum (measured over a 5-min period) was obtained. Flow was then restored to the control level, 5 min were given to allow ventricular pressure to stabilize, and a 144pulse spectrum was obtained. The perfusate was then switched, a 15-min stabilization period was provided, and the entire procedure was repeated. Influence of substrate on lactate production at various coronary flows. In the final protocol (n = 6) 3 ml of coronary effluent were collected from the hearts for analysis of lactate concentration at various coronary flows. Collections were made under steady-state conditions during either glucose or hexanoate perfusion at a control flow of 20 ml/min, then at flows of 12, 7, and 3 ml/min (set in a random manner), and finally during a recontrol period at 20 ml/min. After these collections, perfusate was switched to that containing the other substrate and the procedure repeated. Samples were stored frozen and lactate concentrations were subsequently determined in duplicate.
Data Analysis
Ventricular contractile state was quantified in the first protocol by the slope (E,,) and volume axis intercept (V,) of the ESPVR. End-systolic pressure (Pes) was plotted as a function of ventricular volume (V) and linear regression analysis was applied
The values of Ees and Vo, when considered together, provide a means of indexing left ventricular contractility, which is independent of changes in preload (12, 28). For purposes of comparing data from different experiments, Ee, was normalized to a left ventricular mass of 1 g. There is no accepted method of normalizing V0 for different heart sizes.
Mechanical energy generation by the ventricle under isovolumic conditions was assessed by two indexes. The first was the traditional rate-pressure product (RPP), which was obtained by multiplying developed pressure by heart rate. The second index of work was the pressurevolume area (PVA), which is defined as the area on the pressure-volume plane circumscribed by the ESPVR, the end-diastolic pressure-volume relation (EDPVR), and the systolic portion of the ventricular pressure-volume trajectory (31-33). This index, which has the units of work (mmHg l ml. g-l), has been proposed as a measure of the total mechanical energy liberated during a contraction and is relatively independent of the afterload conditions on the ventricle (31). For the special case of isovolumic contractions where the pressure-volume trajectory is a vertical line on the pressure volume plane, PVA is equal to the area of a triangle with base (V -VO) and height Pe, minus the area beneath the EDPVR between V0 and the actual ventricular volume (Ad,v)
For the purpose of quantifying Adv, the EDPVR was described by a second-order polynomial. The influence of substrate on ventricular efficiency was assessed from plots of MVO~ vs. RPP and PVA. 
Statistics
The substrate dependence of the ESPVRs, MVO~-PVA relations, and the MVO~-RPP relations were tested using multiple linear regression analysis with dummy variables coding for the presence of either glucose or hexanoate. Other data were pooled according to the level of coronary flow, and the statistical significance of differences between glucose and hexanoate perfusate was determined by the paired t test. Bonferroni correction was used in cases when multiple comparisons were made (NMR studies). The impact of flow and substrate on lactate production was tested by two-way analysis of variance. All statistical calculations were performed using a commercially available statistical package (SYSTAT, Evanston, IL) .
RESULTS
Effect of Substrate on Ventricular Performance at Normal Coronary Perfusion Pressure
Results from a representative experiment in which a heart was alternately perfused at normal perfusion pressure with glucose and hexanoate are presented in Fig. 1 . ESPVR (Fig. 1, top) , MVO~-RPP (Fig. 1, middle) , and MVoz-PVA (Fig. 1 , bottom) relations were all described reasonably well by linear regression. EDPVR (also shown in Fig. 1, top) was described well by a second-order polynomial.
Neither ESPVR nor EDPVR were influenced significantly by substrate. However, there was an upward shift of MVO~-RPP and MVO~-PVA relations observed with hexanoate compared with that obtained with glucose, indicating that for a given amount of mechanical work by the ventricle, it consumed more oxygen when perfused with hexanoate.
The mean (&SD) results from IO hearts studied in this series are summarized in Table I for both of these relations by -0.14 X 10d3 ml 0, l beat-l. 8-l (2.5 X lo-' ml O2 l min-l . g-l).
Analysis of the pooled ESPVR data did reveal a statistically significant upward shift in this relation measured during hexanoate perfusion compared with glucose perfusion.
However, the magnitude of this effect, as quantified by the change in V0 values, averaged only 0.02 ml. Thus, although this shift was statistically significant, it was not large in magnitude. There was no detectable influence of substrate on the EDPVR.
Substrate Dependence of Developed Pressure and M?& During Graded Reductions in Coronary Flow
Results from a representative heart studied in the third series of experiments are summarized in Fig. 2 . At high cose perfusion under the two conditions are shown in Fig. 3 (bottom) . Note that a derived parameter, labeled coronary flows, there was relatively little difference in MVo2 for excitation-contraction coupling, has been indeveloped pressure (DP) between glucose and hexanoate eluded and was defined as the difference between Mvo2 perfusion. However, at reduced coronary flow rates, DP measured under unloaded beating conditions and MOON was significantly greater when the hearts were perfused measured during KC1 arrest. with glucose. Analysis of pooled data from the eight Hearts perfused with glucose consumed less oxygen hearts studied, summarized in Table 2 , indicated that, at under both unloaded beating conditions and during KC1 coronary flows of ~15 ml/min, the difference in DP arrest; in addition, the MAO, attributed to excitation-(multiple linear regression analysis).
At a flow of 20 ml/min, ER, averaged 58 t 12% during glucose perfusion and 64 t 10% during hexanoate perfusion (see Table 2 ). As flow decreased, ER, increased for both substrates, but the differences in ER, noted between substrates became much smaller. At the lowest flows tested, 7 ml/min, ER, was 83 t 7% for glucose and 85 t 6% for hexanoate (P = NS), indicating substantial oxygen extraction at these low flows. as detailed in Eqs. I, 3a, and 3b: E,,, mmHg.g* ml-'; V,, ml; a, ml Oz. mmHg-'
. ml-' X lo-"; b, ml 0, s beat-l. g-' X IO-"; c, ml O2 -mmHg-' l 8-l X lo-"; d, ml 0,. min. contraction coupling was also less with glucose than with hexanoate. The mean difference in unloaded MVO~ between glucose and hexanoate perfusion was 0.018 ml 0,. min-l . g? The difference in MvoP measured during KC1 arrest between glucose and hexanoate perfusion was 0.012 ml O2 l min-l . g-l, so that basal M%~o, decreased by 30% with glucose. The Mvo2 attributed to excitationcontraction coupling was 0.006 ml O2 l min-' l g-l less with glucose than with hexanoate, so that MVoS for excitation-contraction coupling decreased by only 9% with glucose. Thus two-thirds of the difference between unloaded Mvo2 measured with the two substrates was accounted for by changes in basal MOON, and only onethird was attributed to excitation-contraction coupling mechanisms.
Influence of Substrate on Intracellular pH, Pi, and High-Energy Phosphates
Representative 31P-NMR spectra obtained from one heart during glucose and hexanoate perfusion at control (20 ml/min) and low (3 ml/min) flow rates are shown in Fig. 4 . On moving from high to low flow, Pi increased and PCr decreased significantly during both hexanoate and glucose perfusion. However, the degree to which the concentrations of these compounds (i.e., areas under the respective peaks) changed was much greater when the heart was perfused with hexanoate. Results from the seven hearts studied in this series are summarized in Fig.  5 , which shows the mean (*SD) value of each of the parameters measured at the control flow, then at the reduced flow, and after reaching a steady state following reflow during perfusion with each substrate. As for the previous series of hearts, DP was similar at the control flow but less at the low flow with hexanoate perfusion (P < 0.05). DPs measured under control and reflow conditions were not statistically different from each other. There were no statistically significant differences in end-diastolic pressure between the substrates or between different flow rates. [Pi] in that [PCr] was significantly greater at low flow during glucose than during hexanoate perfusion (5.7 t 1.83 vs. 4.7 t 1.55 mol/g wet wt, respectively, P = 0.001). Concentrations of ATP, quantified by the calibrated area under the (p-P)ATP peak, were not statistically different between control, low-flow, or reflow conditions, nor were there differences introduced by substrate. Intracellular pH decreased during low flow from an average of 7.15 t 0.05 under control conditions to 7.05 t 0.07 with hexanoate and to 7.01 t 0.06 with glucose perfusion (P = NS between glucose and hexanoate).
Impact of Substrate and Coronary Flow on Lactate Production.
At a coronary flow of 20 ml/min, lactate production averaged 0.37 t 0.20 ,umoL min-' l g wet wt-' during hexanoate perfusion and 0.70 t 0.29 pmol= min. g-l during glucose perfusion (P < 0.001). Lactate production did not change significantly as flow was decreased to 12 or 7 ml/min with either substrate. There was a trend for lactate production to increase during glucose perfusion at a flow of 3 ml/min (to 1.06 t 0.31 prnol= min-' l g-l, P = 0.04 by paired t test compared with control).
DISCUSSION
The impact of metabolic substrate on contractile strength and the relation between ventricular work and oxygen consumption were assessed at varied coronary flows. There was no significant impact of substrate on contractile strength at a normal coronary perfusion pressure. However, at lower flows, contractile strength was depressed by hexanoate compared with glucose perfu- and low-flow (3 ml/min) conditions measured in same heart with glucose perfusate and hexanoate perfusate. These are 144 pulse spectra.
Peaks are as follows: a, phenylphosphonic acid (100 mM concentration within intraventricular balloon); b, inorganic phosphate; c, phosphocreatine; d, (r-P)ATP; e, (a-P)ATP; f, (@-P)ATP.
sion. The relation between MVO~ and mechanical work (indexed by either RPP or PVA) shifted upward in a parallel manner on switching from glucose to hexanoate at both high and !ow flows. Thus FFA perfusion imposed an increase in MVoz that was independent of the amount of mechanical energy generation by the ventricle. This was accompanied by a work load-independent reduction in lactate production, suggesting a decreased contribution of anaerobic (glycolytic) ATP generation during hexanoate perfusion.
Comparison of oxygen consumption measurements made during unloaded contractions and during KC1 arrest indicated that two-thirds of the increase in MVO~ can be attributed to an increase in basal metabolic requirements and one-third to an increase in the oxygen consumed by excitation-contraction coupling mechanisms.
This obligate increase in energy expenditure, not related to useful mechanical work, indicates a decrease in overall ventricular efficiency (defined in terms of the ratio between mechanical work and oxygen consumption) during medium-chain FFA perfusion. The consequences of this inefficiency were that at low coronary flows developed pressures were less, [ (5, 7, 8, 24, 27) . In most of the previous studies, comparisons of MvoZ measured during glucose and FFA perfusion have been made at a single hemodynamic loading condition in each heart and efficiency indexed by a ratio between work and MVO,. It is not possible to determine from such a limited evaluation the mechanisms by which myocardial efficiency is altered and whether the observed changes in MVO, result from increased energy demands for mechanical activity, basal metabolism, or other processes. In contrast, such information may be inferred when the energetics of ventricular contraction are evaluated, as in the present study, within the context of a relation between mechanical work generation and oxygen consumption determined over a range of loading conditions. Such an approach has been proposed by Suga and colleagues (31-33) with regard to interpretation of changes in the MVO~-PVA relation. The slope of the relation has been proposed to reflect the metabolic efficiency of pressure generation by the ventricle. The absence of an influence on slope by metabolic substrate therefore suggests that the predominant energy-wasting effect of FFA does not involve inefficiency of contraction-dependent oxygen utilization. The MVO~ axis intercept of the relation has been proposed to reflect the sum of energy required for basal metabolism plus excitation-contraction coupling. The influence of substrate on both of these were evaluated (Fig. 3) . The increase in basal MvoB accounted for two-thirds of the total increase observed during hexanoate perfusion, whereas the remainder was attributed to energy for excitation-contraction coupling. Although excess concentrations of FFA have been shown to depress contractile strength with little impact on Mvoz at low coronary flows (14, 18, 21), the effect of substrate on the relation between MOON and work as coronary flows is changed has never been evaluated prior to this study. Hexanoate caused a parallel upward shift of this relation (Fig. 2) . This was a manifestation of an increase in MTjoa with constant contractile state at high flows and a decrease in contractile state with constant Mvo2 at low flows. Both of these reflect a decrease in efficiency during hexanoate perfusion.
Mechanisms
by Which FFA Decrease Myocardial Efficiency FFA can impact on myocardial metabolism in a number of ways that can cause increased Mvo2 over that measured during glucose perfusion. First, on theoretical grounds, the ratio between the rate of ATP production and the rate of oxygen consumption (i.e., stoichiometric ratio of P/O) is 2.7 for FFA and 3.0 for glucose. If this were the sole explanation for the effects of FFA, then a 10% increase in Mvo2 would be expected at any level of pressure generation upon switching from glucose to hexanoate perfusion. Furthermore, via this mechanism, the oxygen consumption attributed to various processes (e.g., contraction, basal metabolism, and excitation-contraction coupling) would be expected to increase by the same proportion.
However, the overall increase in Mvo2 was 
Limitations
A limitation of the present study relates to the use of crystalloid solutions rather than blood to perfu .se the myocard carrying .ium. Bet ause of markedly decreased oxygencapacity, coronary vascular resistance is much lower in crystalloid perfused hearts and the flow needed to maintain coronary perfusion pressure within a physiological range is much greater than with blood perfusion. This could impact not only on tissue oxygenation but may also alter the normal mechanical coupling between coronary vasculature and myocardial performance. Despite this limitation, the data of the present study are in striking accordance with data obtained in blood-perfused hearts demonstratin formance and MVO (14, 18).
.g the effects of excess FFA on per-2 in high-and low-flow conditions Many previous studies of fatty acid metabolism have employed long-chain fatty acids. Our choice of hexanoate was based on the fact that this medium-chain fatty acid does not require transport into mitochondria. Thus we can exclude the possibility that the observations made at low coronary flows were caused by the impact of these conditions on fatty acid transport that might h .ave limited substrate availability had long-chain fatty acids been used.
Implications
Myocellular integrity and viability can be ensured during periods of low coronary flow only if the balance between energy supply and demand is maintained (11). Maintenance of this balance is reflected by preservations of high-energy phosphate concentrations within the cell. The results of the present study suggest that the proportion of total chemical energy available to support contraction and excitation-contraction coupling is decreased during perfusion with fatty acids alone compared with that available during perfusion with glucose alone. This had no significant metabolic effect at normal perfusion pressures; but when flow was reduced, high-energy phosphate concentrations could not be maintained as well during fatty acid perfusion compared with glucose perfusion. Thus the degree to which coronary flow can be decreased and still maintain the energy supply-demand balance is reduced by fatty acids. Therefore the results of the present study suggest that strategies that would both enhance glucose utilization and inhibit fatty acid utilization may limit myocardial damage during periods of low coronary flow. Previous clinical attempts to manipulate metabolism during ischemic episodes have been predominantly limited to enhancing glucose utilization, and results of these studies have not demonstrated a consistent benefit (2) . Interestingly, results of several animal studies have suggested that myocardial efficiency can be improved by the administration of agents that inhibit fatty acid utilization (10, 22). However, clinical testing of such strategies must await the availability of fatty acid inhibitors that can be used in patients.
Conclusion
The results of this study indicate that oxygen consumption is increased during hexanoate compared with glucose perfusion when work load is the same. Approximately two-thirds of the added oxygen requirements are attributable to an increase in basal metabolism and about one-third to an increase in energy for excitation-contraction coupling. Whereas at normal perfusion pressures fatty acids increase oxygen consumption without influencing contractile strength, it has been hypothesized previously that at decreased flow fatty acids would decrease function with no impact on oxygen consumption (14). This important hypothesis is confirmed for the first time by the results of the present study. Finally, both high-energy phosphates and ventricular performance are preserved better when substrate is switched from fatty acid to glucose at low coronary flow. This observation illustrates an important consequence of the decrease in metabolic efficiency caused by fatty acids. 
